Actual Medicinal Product (AMP) Opizone 50mg tablets (Genus Pharmaceuticals Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Notes

Protect from light and moisture.

Provenance

Compatibility recommendation derived from Naltrexone 50mg tablets (Accord Healthcare Ltd).

Generic
Naltrexone
Formulation
Naltrexone 50mg tablets
  • Naltrexone
    • Naltrexone 50mg tablets

      • Opizone 50mg tablets (Genus Pharmaceuticals Ltd)